Patient Centered Outcomes HTA, TA Director
As part of International HEOR & PCO in International Value & Access, the Patient Centered Outcomes (PCO) HTA, TA Director within the HEOR TA teams, in partnership with HEOR leads co‑leads the PCO reimbursement strategy that enables measurements of patient centered outcomes to support robust payer value propositions and evidence for HTAs, optimizing international access for prioritized Novartis assets.
About The Role
The PCO HTA TA Director will oversee one therapeutic area (e.g., CRM, immunology, oncology, or neurosciences) and their responsibilities will span multiple assets/indications. They will support and guide other members of the HEOR TA team in input or development of plans such as Health Technology Assessment Strategy Plans and Integrated Evidence Plans.
Key Responsibilities
Co‑lead with the HEOR TA lead the development, delivery, and communication of a compelling PCO reimbursement strategy within the HTAP (Health Technology Assessment Strategy Plan), IPAS (Integrated Product Access Strategy), 1BP (One Brand Plan) and aligned with the Integrated Evidence Plan (IEP).
In partnership with the PCO COE, Global Program Teams, HEOR Leads, HTA Evidence Synthesis, Access, Medical Affairs, and AQS Biostat, ensure that the PCO measurement strategy includes patient reported outcomes and health utilities of relevance for international HTAs and payers into the clinical development program.
Participate in and co‑lead projects on behalf of the OnePCO Alignment Forum to ensure PCOs critical for HTAs and payers are included in clinical trials, non‑interventional studies and real‑world studies for select assets and coordinate with countries to ensure alignment on local HTA and payer needs.
Drive understanding of HTA requirements for PCO, health utility assessment, and adoption of standards and best practices by key markets.
Lead health state valuation projects via development and management of Time Trade‑Off (TTO) or Standard Gamble (SG) studies where appropriate.
Assist in scientific discussions with HTA agencies, particularly scientific advice from entities such as EU HTA JSC, NICE, CADTH for PRO/PCO endpoints, MCIDs, and by preparing appropriate briefing documents and dossiers to ensure a robust patient value proposition is included.
Develop strategic scientific communication plans, including submission and presentation of research in peer‑reviewed journals and scientific/methodological congresses.
Engage with external thought leaders, identify research collaborations/partnerships, and represent Novartis with external stakeholders (academic institutions, HTA agencies…) to monitor and shape the external environment with respect to patient centered outcomes research and evolving evidentiary standards for utility endpoints, ensuring awareness of these changes for Novartis.
Lead above‑brand research projects/initiatives to pilot innovative methodologies for value demonstration and elevate internal standards/best practices within International Value and Access and at Novartis with cross‑functional partners.
Essential Requirements
8+ years of Pharma Industry experience with 5+ years in HEOR roles in pharmaceutical companies or consulting, with at least 3 years demonstrating specific leadership of health utility projects.
Advanced Degree in a relevant field.
Experience evaluating, developing and validating PRO/PCO instruments to meet HTA reimbursement requirements.
In‑depth understanding of key patient centered outcomes measurement systems – e.g., EuroQoL, Quality Metric Short‑Form measures, HUI, etc.
Ability to lead in a cross‑functional environment.
Ability to manage multiple priorities in a rapidly changing environment.
Ability to work collaboratively to leverage other HEOR capabilities (strategy, regions, countries, COE PCO).
Desirable Requirements
Ph.D., M.D., MBA, MSc or equivalent. Strong external interfaces and network: KOLs, clinical research & scientific groups, payers, and policy organizations.
Experience conducting and evaluating PCO measures from conceptualization through negotiation with international health authorities and experience in HTA submissions.
Location
This role can be based in the UK (London) but also in Dublin, Ireland or Basel, Switzerland.
Benefits
Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: Novartis Life Handbook.
Commitment to Diversity & Inclusion
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Why Novartis
Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture.
Benefits and Rewards
Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: https://www.novartis.com/careers/benefits-rewards.
#J-18808-Ljbffr